2026. MOLECULAR DOCKING AND MM/GBSA BINDING FREE ENERGY EVALUATION OF NAPROXEN-AZETIDINONE HYBRID DERIVATIVES AS POTENTIAL PREFERENTIAL COX-2 INHIBITORS: COMPARATIVE STUDY WITH MELOXICAM, ISORHAMNETIN, AND NAPROXEN FOR OSTEOARTHRITIS. Integrative Perspectives of Social and Science Journal. 3, 06 Juni (Jun. 2026), 4621–4635.